Juno Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
555 Richmond Street West Ste 512, Toront...Phone Number
(905) 881-4410Website
www.junopharm.comRevenue
$11.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
4
1
1
1
1
About Juno Pharmaceuticals
Juno Pharmaceuticals was founded in 2012 by group of experienced international pharmaceutical executives. The company is a fast growing global specialty pharmaceutical company. To date the company has launched 16 generic and branded pharmaceutical products in the company's territories with approvals pending for an additional 30 products.Explore more
Juno Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Juno Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Juno Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Juno Pharmaceuticals
Click to see if Juno Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Juno Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Juno Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Juno Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Juno Pharmaceuticals recently announced quarterly report
Check out if Juno Pharmaceuticals is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Juno Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Juno Pharmaceuticals
Compare insights from companies similar to Juno Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Juno Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Juno Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Juno Pharmaceuticals.
Juno Pharmaceuticals Tech Stack
A closer look at the technologies used by Juno Pharmaceuticals
Most Recent Scoops
Open Position
Open Position
Open Position
Project
Spending/Investment
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Juno Pharmaceuticals News & Media
FluidAI Medical Raises $15M in Series A Funding
FluidAI Medical (formerly known as NERv Technology Inc.), a Kitchener, Canada-based company leveraging artificial intelligence (AI) for postoperative patient monitoring, raised $15M in Series A funding. The round was led by SOSV and Graphene Ventures with participation from Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital, Kyto Technology & Life Science Inc., Juno Pharmaceuticals, […] The post FluidAI Medical Raises $15M in Series A Funding appeared first on FinSMEs.Juno Pharmaceuticals Acquires Omega Laboratories, Propelling Canada’s Pharmaceutical Industry Forward
TORONTO--(BUSINESS WIRE)--Today, Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers. The new combined company is now one of the largest specialty generic injectable businesses in Canada with domestic manufacturing capabilities. “We are proud of this acquisition that solidifies Juno’s ability to improve drJuno Pharmaceuticals Approved to Import Ketamine, Providing Immediate Relief for Hospitals Across Canada
TORONTO--(BUSINESS WIRE)--Juno Pharmaceuticals Canada (“Juno”), a Canadian specialty pharmaceutical company, announced it has received approval from Health Canada to import ketamine solution for injection pursuant to Health Canada’s exceptional importation and sale guidelines. Juno has procured 25,000 units for immediate release, providing a 6-week supply to the entirety of the Canadian market. Health Canada has approved ketamine for use as a sedative and painkiller in hospital settings. As sucJuno Pharmaceuticals Partners With Rosemont Pharmaceuticals as Exclusive Canadian Distributor to Offer Previously Inaccessible Medicines
TORONTO--(BUSINESS WIRE)--Juno Pharmaceuticals Canada (“Juno”), a Canadian specialty pharmaceutical company, announced its partnership with U.K. based developer, manufacturer and global supplier of novel, Rx, oral liquid medicines, Rosemont Pharmaceuticals (“Rosemont”), as its exclusive Canadian distributor. Through this partnership, several of Rosemont’s oral liquid solutions will be filed with Health Canada in the coming months. Oral liquid medicines can provide an easier to swallow, more app
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Juno Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Juno Pharmaceuticals was founded in 2012 by group of experienced international pharmaceutical executives. The company is a fast growing global specialty pharmaceutical company. To date the company has launched 16 generic and branded pharmaceutical products in the company's territories with approvals pending for an additional 30 products.... Read More
